Pacira BioSciences Inc. (PCRX)
24.93
-0.37 (-1.46%)
At close: Mar 28, 2025, 3:57 PM
24.23
-2.81%
Pre-market: Mar 31, 2025, 04:11 AM EDT
Pacira BioSciences Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Net Income | -99.56M | 41.95M | 15.91M | 41.98M | 145.52M | -11.02M | -471K | -42.61M | -37.95M | 1.86M | -13.72M | -63.91M | -52.28M | -43.33M | -27.15M | -31.71M | -41.86M |
| Depreciation & Amortization | 78.78M | 75.57M | 91.5M | 28.55M | 19.91M | 19.58M | 13.16M | 13.83M | 12.92M | 11.47M | 10.04M | 5.75M | 5.65M | 4.31M | 4.25M | 4.43M | 3.83M |
| Stock-Based Compensation | 51.17M | 47.9M | 48.09M | 42.25M | 39.92M | 33.65M | 31.73M | 31.6M | 31.25M | 33.37M | 24.82M | 11.51M | 4.78M | 2.49M | 23K | 524K | 242K |
| Other Working Capital | n/a | -31.24M | -23.11M | 6.49M | -9.21M | 9.6M | 2.87M | -3.56M | -1.43M | 3.59M | 6.77M | -941K | -18.24M | 498K | -1.12M | 7.03M | 9.84M |
| Other Non-Cash Items | 138.37M | 19.39M | 14.15M | 20.75M | 22.68M | 31.75M | 14.39M | 11.67M | 4.57M | 4.58M | 4.63M | 4.42M | 592K | -45.14M | -675K | 185K | -5.18M |
| Deferred Income Tax | 20.62M | 15.62M | -7.95M | 10.87M | -126.61M | 5.33M | 919K | 5.87M | 389K | 58K | 158K | 3.43M | 1.06M | 48.18M | 11K | 1.71M | 426K |
| Change in Working Capital | n/a | -45.78M | -16.43M | -18.67M | -24.39M | -8.77M | -10.86M | -2.57M | 22.28M | -22.34M | -456K | -4.42M | -29.93M | 2.48M | -1.34M | 4.02M | 13.36M |
| Operating Cash Flow | 189.39M | 154.65M | 145.27M | 125.72M | 77.03M | 70.52M | 48.87M | 17.79M | 33.45M | 29M | 25.47M | -43.22M | -70.13M | -31M | -24.88M | -20.84M | -29.19M |
| Capital Expenditures | -10.64M | -15.16M | -30.08M | -45.87M | -37.8M | -10.16M | -14.51M | -19.27M | -24.71M | -41.27M | -21.89M | -12.79M | -18.26M | -6.17M | -6.77M | -5.51M | -5.84M |
| Acquisitions | n/a | n/a | -32M | -437.23M | -1.16M | -119.31M | -7M | -15M | -16M | -7M | -13M | -2M | -10M | n/a | n/a | n/a | n/a |
| Purchase of Investments | -252.21M | -144.37M | -400.69M | -611.49M | -546.52M | -318.48M | -363.25M | -502.75M | -192.81M | -189.08M | -164.3M | -114.3M | -54.05M | -29.97M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 179.57M | 237.07M | 237.58M | 1.08B | 307.87M | 319.47M | 405.19M | 321.71M | 171.63M | 217.24M | 80.29M | 85.56M | 53.12M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | -32M | -4M | -239.81M | -638K | 157K | -8.46M | 143K | -119K | -433K | -31K | -338K | 14K | 1K | n/a | 2K |
| Investing Cash Flow | -83.28M | 77.54M | -225.19M | -20.79M | -277.61M | -128.49M | 20.58M | -223.76M | -61.75M | -20.23M | -119.34M | -43.56M | -29.52M | -36.12M | -6.77M | -5.51M | -5.84M |
| Debt Repayment | 76.61M | -180.76M | -427.69M | 363.75M | 192.62M | -338K | n/a | 226.81M | -4K | -1.47M | n/a | 92.5M | 1.25M | n/a | 50.7M | 21.04M | n/a |
| Common Stock Repurchased | -25M | -106K | 2.95M | 2.81M | -33.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2K | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | -2.67M | -1.62M | -4.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -34.25M | -2.16M | 26.17M | 16.94M | 31.3M | 4.01M | 8.95M | -2.65M | 7.26M | 12.17M | 8.42M | -3.33M | -495K | 136K | 2K | 3K | 40.17M |
| Financial Cash Flow | 17.36M | -183.03M | -401.53M | 380.69M | 222.3M | 3.67M | 8.95M | 224.16M | 7.26M | 10.7M | 118.88M | 89.17M | 63.61M | 87.16M | 50.7M | 21.04M | 40.17M |
| Net Cash Flow | 123.48M | 49.16M | -481.44M | 485.62M | 21.73M | -54.3M | 78.4M | 18.18M | -21.04M | 19.46M | 25M | 2.39M | -36.04M | 20.04M | 19.06M | -5.31M | 5.15M |
| Free Cash Flow | 178.75M | 139.49M | 115.2M | 79.85M | 39.23M | 60.36M | 34.36M | -1.48M | 8.74M | -12.27M | 3.58M | -56.01M | -88.39M | -37.17M | -31.65M | -26.35M | -35.03M |